Pityriasis rosea following SARS-CoV-2 vaccination: A case series
J Cosmet Dermatol
.
2021 Oct;20(10):3080-3084.
doi: 10.1111/jocd.14372.
Epub 2021 Aug 7.
Authors
Selami Aykut Temiz
1
,
Ayman Abdelmaksoud
2
,
Recep Dursun
3
,
Koray Durmaz
4
,
Roxanna Sadoughifar
5
,
Abdulkarim Hasan
6
Affiliations
1
Department of Dermatology, Konya Ereğli State Hospital, Konya, Turkey.
2
Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
3
Department of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
4
Department of Dermatology, Bozüyük State Hospital, Bilecik, Turkey.
5
Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
6
Department of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
PMID:
34363731
PMCID:
PMC8447003
DOI:
10.1111/jocd.14372
No abstract available
Keywords:
COVID-19; pityriasis rosea; vaccine.
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Pityriasis Rosea* / etiology
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines